Clinical trial
A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatment of Advanced Prostate Cancer
NCT01081873 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatment of Advanced Prostate Cancer
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- December 31, 2010
- Enrollment
- 2,717 (actual)
- Sites
- 135
Conditions
As the registry lists them; a condition with its own page is linked.
prostatic neoplasm